Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1975;45:267-270
© 1975 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PEREZ-LOPEZ, F R
Right arrow Articles by RONCERO, M C
Right arrow Search for Related Content
PubMed
Right arrow Articles by PEREZ-LOPEZ, F R
Right arrow Articles by RONCERO, M C

Induced Prolactin Release in Women Under Long-Term Medroxyprogesterone Acetate Treatment

F R PEREZ-LOPEZ, MD and M C RONCERO, MD

From the Department of Obstetrics and Gynecology, San Rafael Hospital, Barcelona, Spain

Abstract

Medroxyprogesterone acetate (MPA) was administered, as a contraceptive, by intramuscular injection in doses of 150 mg every 90 days, or 300—150 mg every 180 days, to 5 women, over a period of 27 to 42 months. No major adverse reactions were reported, and the minor side elfects were only as frequent as those reported for oral contraceptives. The LH basal levels were depressed in all subjects; FSH and prolactin serum concentrations were within the range found in normally cycling women. Synthetic TRH released prolactin in 4 subjects, and the maximal response was within 10–20 minutes after TRH injection. In the fifth case there was no prolactin release.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the American College of Obstetricians and Gynecologists.